JLJerry L. Lowder

Jerry L. Lowder

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jerry L. Lowder has a total of 171 co-authors. Here are the top co-authors by number of shared publications:

  • Chiara Ghetti

    Department of Obstetrics and Gynecology, Washington University in St Louis School of Medicine, St Louis, USA

    7 shared publications
  • Siobhan Sutcliffe

    Department of Surgery, Washington University in St Louis School of Medicine, St Louis, USA

    7 shared publications
  • Alayne D. Markland

    Division of Geriatrics, Department of Internal Medicine, University of Utah, Salt Lake City, UT; Geriatric Research, Education, and Clinical Center at the Birmingham Veterans Affairs Health Care System; Birmingham, AL

    6 shared publications
  • Ariana L. Smith

    Division of Urology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania

    5 shared publications
  • Diane K. Newman

    Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania USA

    5 shared publications
  • Elizabeth R. Mueller

    Department of Obstetrics and Gynecology Loyola University Chicago Chicago Illinois USA

    5 shared publications

Latest Publications

  • Experiences of Maternal Autonomy in Childbirth and Perinatal Care in the United States: A Systematic Review and Meta‐Synthesis of Qualitative Studies

    by Victoria L. Brown, Maddie Borowsky, Arya Catna, Rachel Yoken, Olivia Emerson, Josephine Ofori‐Apau, Amy Ayala, Emily Gallaher, Ange Muyumba, Claire Gwak, et al.

    Background: Over the past decade, major legal and policy shifts have reconfigured the reproductive health landscape in the United States (US), renewing interest in reproductive and bodily autonomy. While much of this attention has focused on abortion access, autonomy during labor, delivery, and the immediate postpartum period remains underexamined. This review aimed to synthesize qualitative evidence on experiences of maternal autonomy in childbirth and the factors that influence perinatal care decision‐making. Methods: We searched Ovid MEDLINE, EMBASE, Scopus, JSTOR, and ClinicalTrials.gov for studies published between 2014 and February 2025. Eligible studies were appraised using the COREQ framework, and findings were extracted, meta‐summarized, and thematically synthesized. Results: 39 studies including 4919 participants were synthesized. Most were conducted in urban areas of the US South and Upper‐Midwest, with limited representation from rural or other regions. Participants frequently cited structural barriers as limiting autonomy and access to preferred care. Clinical power dynamics and racial inequities further constrained decision‐making. Mothers navigated these challenges using strategies such as hiring doulas, modifying the birthing environment, or pursuing alternative birth settings. Conclusion: Maternal autonomy in childbirth and perinatal care is shaped by complex structural, relational, and experiential factors that extend beyond individual “choice.” Persistent barriers underscore the need to integrate reproductive and maternal autonomy across the full pregnancy continuum. Linking decisions about “whether” and “when” to have children with decisions about “how” to deliver them can support cross‐specialty approaches in obstetrics that better reflect the temporal, lived experience of decision‐making across fertility, pregnancy, and postpartum care.

  • Open Access

    Associations Between Vaginal Angle and Pelvic Organ Prolapse: Exploration of a Possible New Screening Tool

    by Kimberley Chiu, Chiara Ghetti, Melanie R. Meister, Jung A. Lee, Ratna Pakpahan, Siobhan Sutcliffe, Jerry L. Lowder

    Introduction and Hypothesis: The objective of this study was to explore if vaginal angle is associated with pelvic organ prolapse (POP) stage and predominant compartment utilizing a simple physical examination measurement as a possible screening tool for POP. Methods: We conducted an exploratory cross-sectional analysis of women from our urogynecology clinics who underwent POP Quantification (POP-Q) examination and vaginal-angle measurements. Angle at rest and with Valsalva were measured using a POP-Q stick placed in the vaginal apex and a goniometer with attached line level (0° reference = horizontal). Angle change was calculated (resting – Valsalva). Reproducibility of angle measurements between examiners was assessed ( r = 0.92–0.95, p < 0.0001). Associations for vaginal angle with POP stage and predominant compartment were estimated using linear regression, adjusting for age, parity, body mass index, hysterectomy status, and prior POP surgery. Results: Data from 477 women were included, 78 with POP-Q stage 0 support, 156 with stage 1, 111 with stage 2, and 132 with stages 3–4. A total of 241 patients had anterior-predominant, 35 apical-predominant, 83 posterior-predominant, and 40 equal anterior/posterior POP. Resting angle was higher for POP-Q stage 1 than 0 (adjusted β = 3.6, 95% confidence interval [CI]: 0.8 to 6.5), and Valsalva change angles were higher for POP-Q stages 1/2 than for 0 (adjusted βs: 6.8 to 8.0, p < 0.05). Valsalva and change angles were greatest with posterior-predominant POP (adjusted βs compared with anterior-predominant 3.3 to 4.2, p < 0.05). Conclusions: Using a simple clinical measurement, we found that vaginal angles were associated with POP stage, particularly transition from “normal support” (0) to stage 2, and with predominant compartment, particularly posterior-predominant POP. Larger studies are warranted to investigate the reproducibility of these findings and clinical implications.

  • Open Access

    Vaginal Antisepsis for Major Gynecologic Surgeries Using Chlorhexidine Gluconate versus Povidone Iodine: A Systematic Review and Meta-Analysis

    by Yasmin Dias, Feven Gebrekidan, Jerry L. Lowder, Siobhan Sutcliffe, Lauren Yaeger, Sabrina Lara, Amanda Godoi, Cintia Gomes

    OBJECTIVE: We performed a systematic review and meta-analysis (SRMA) of post-surgical outcomes, comparing chlorhexidine gluconate (CHG) versus povidone iodine (PI) for vaginal antisepsis of major gynecologic procedures. DATA SOURCES: Ovid Medline, Embase, Scopus, Embase, Cochrane, and Clinicaltrials.gov were searched between 1986 and December 2023, for studies comparing CHG with PI for vaginal antisepsis of major gynecologic operations. STUDY ELIGIBILITY CRITERIA: We included Randomized Controlled Trials (RCTs) and non-RCTs comparing CHG to PI for vaginal antisepsis of major gynecologic operations. The primary outcome was surgical site infections (SSIs) and the secondary outcome was urinary tract infections (UTIs) and vaginal irritation. METHODS: Summary estimates were calculated by fixed effects models when I2 ≤ 25% and by random effects models when I2 > 25%. Statistical analysis was performed using RevMan 5.4.1. The protocol for this systematic review was registered on PROSPERO (ID CRD42022378101). RESULTS: Nine studies met the inclusion criteria, four of which were randomized controlled trials (RCTs). 9538 patients were included, 4300 (45%) of whom were allocated to CHG and 5238 (55%) to PI. No statistically significant difference in SSI incidence was found for vaginal antisepsis with CHG versus PI in pooled analyses (n= 9538 patients; RR 1.20; 95% CI 0.92-1.57; I2 =0%). In contrast, a significantly higher risk of UTIs was observed for vaginal antisepsis with CHG than with PI (n=6061 patients; RR 1.48 95% CI 1.03-2.14; I2 = 0%). CONCLUSION: In our SRMA, there were no significant differences in SSI risk when either CHG or PI was utilized for antiseptic vaginal preparation. Interestingly, vaginal antisepsis with PI was associated with a lower incidence of post-operative UTIs following major gynecologic surgery. Our findings support current guidelines that form of vaginal antisepsis can be used for SSI prevention. They also suggest that PI may result in fewer postoperative UTIs but further randomized studies are needed to support these findings. Key words: surgical site infection, surgical wound infection, urinary tract infection, urogynecologic surgery, Chlorhexidine, Povidone Iodine, surgical antiseptic,

  • Urologic Chronic Pelvic Pain Syndrome: A Scoping Review of Syndrome‐Specific Instruments

    by Arya Catna, Victoria L. Brown, Claire Gwak, Deeksha Kanagarag, Madeline Meyer, Srinitya Rapolu, Ratna Pakpahan, Lauren Yaeger, James W. Griffith, Aimee S. James, et al.

    Objective: To facilitate research on interstitial cystitis/bladder pain syndrome (IC/BPS) and chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) symptom variability or flares, we reviewed the published literature to document existing data collection instruments (e.g., questionnaires and diaries), and to identify those relevant for flare research.Methods: Seven databases were searched systematically for articles describing the development of instruments: (1) specific for IC/BPS, CP/CPPS, or both; and (2) intended for use by investigators beyond the development team. In total, 1216 abstracts and 79 full‐text articles were reviewed, and data were extracted in duplicate.Results: We identified 17 instruments, 11 for IC/BPS, 5 for CP/CPPS, and 1 for both. In total, 13 instruments (12 questionnaires and 1 electronic diary) assessed symptoms for diagnostic, symptom evaluation, and/or symptom monitoring purposes, and included items assessing the presence, location, intensity (mostly typical intensity), and/or amount of time experienced pelvic pain and/or urinary symptoms. No instruments included items related to symptom variability or flares.Conclusion: In addition to describing existing instruments for future urologic CPPS research, our review identified a lack of validated instruments for flares. Future studies should address this gap to facilitate rigorous research on this understudied topic.


  • Reliability of Uroflowmetry Pattern Interpretation in Adult Women

    by Leslie M. Rickey, Elizabeth R. Mueller, Diane K. Newman, Alayne D. Markland, Chloe Falke, Kyle Rudser, Ariana L. Smith, Margaret G. Mueller, Jerry L. Lowder, Emily S. Lukacz, et al.

    Introduction: Uroflowmetry is often used to assess lower urinary tract symptoms (LUTS). Criteria for characterization of flow patterns are not well established, and subjective interpretation is the most common approach for flow curve classification. We assessed the reliability of uroflowmetry curve interpretation in adult women.Materials and Methods: Uroflowmetry studies were obtained in 296 women who participated in an observational cohort study. Four investigators with expertise in female LUTS and urodynamics reviewed and categorized each tracing for interrater reliability. A random subset of 50 tracings was re‐reviewed by each investigator for intrarater reliability. The uroflowmetry tracings were rated using categories of continuous, continuous fluctuating, interrupted, and prolonged. Other parameters included flow rate, voided volume, time to maximum flow, and voiding time. Agreement between raters is summarized with kappa (k) statistics and percentage where at least three raters agreed.Results: The mean age of participants was 44.8 ± 18.3 years. Participant age categories were 18–24 years: 20%; 25–34 years: 17%; 35–64 years: 42%; 65+ years: 18%. Nine percent described their race as Asian, 31% Black, 62% White, and 89% were of non‐Hispanic ethnicity. The interrater reliability was highest for the continuous flow category (k = 0.65), 0.47 for prolonged, 0.41 for continuous fluctuating, and 0.39 for interrupted flow curves. Agreement among at least three raters occurred in 74.3% of uroflow curves (69% for continuous, 33% for continuous fluctuating, 23% for interrupted, and 25% for prolonged). For intrarater reliability, the mean k was 0.72 with a range of 0.57–0.85.Conclusions: Currently accepted uroflowmetry pattern categories have fair to moderate interrater reliability, which is lower for flow curves that do not meet “continuous” criteria. Given the subjective nature of interpreting uroflowmetry data, more consistent and clear parameters may enhance reliability for use in research and as a screening tool for LUTS and voiding dysfunction.Trial Registration: Parent trial: Validation of Bladder Health Instrument for Evaluation in Women (VIEW); ClinicalTrials.gov ID: NCT04016298.


  • Preoperative prolapse phenotype is predictive of surgical outcome with minimally invasive sacrocolpopexy

    by Jerry L. Lowder, Peinan Zhao, Megan S. Bradley, Lauren E. Giugale, Haonan Xu, Steven D. Abramowitch, Philip V. Bayly


  • Open Access

    A Treatment Algorithm for High-Tone Pelvic Floor Dysfunction

    by Michele Torosis, Erin Carey, Kristin Christensen, Melissa R. Kaufman, Kimberly Kenton, Rhonda Kotarinos, H. Henry Lai, Una Lee, Jerry L. Md Lowder, Melanie Meister, et al.

    OBJECTIVE: To develop evidence- and consensus-based clinical practice guidelines for management of high-tone pelvic floor dysfunction (HTPFD). High-tone pelvic floor dysfunction is a neuromuscular disorder of the pelvic floor characterized by non-relaxing pelvic floor muscles, resulting in lower urinary tract and defecatory symptoms, sexual dysfunction, and pelvic pain. Despite affecting 80% of women with chronic pelvic pain, there are no uniformly accepted guidelines to direct the management of these patients. METHODS: A Delphi method of consensus development was used, comprising three survey rounds administered anonymously via web-based platform (Qualtrics XM) to national experts in the field of HTPFD recruited through targeted invitation between September and December 2021. Eleven experts participated with backgrounds in urology, urogynecology, minimally invasive gynecology, and pelvic floor physical therapy (PFPT) participated. Panelists were asked to rate their agreement with rated evidence-based statements regarding HTPFD treatment. Statements reaching consensus were used to generate a consensus treatment algorithm. RESULTS: A total of 31 statements were reviewed by group members at the first Delphi round with 10 statements reaching consensus. 28 statements were reposed in the second round with 17 reaching consensus. The putative algorithm met clinical consensus in the third round. There was universal agreement for PFPT as first-line treatment for HTPFD. If satisfactory symptom improvement is reached with PFPT, the patient can be discharged with a home exercise program. If no improvement after PFPT, second-line options include trigger or tender point injections, vaginal muscle relaxants, and cognitive behavioral therapy, all of which can also be used in conjunction with PFPT. Onabotulinumtoxin A injections should be used as third line with symptom assessment after 2–4 weeks. There was universal agreement that sacral neuromodulation is fourth-line intervention. The largest identified barrier to care for these patients is access to PFPT. For patients who cannot access PFPT, experts recommend at-home, guided pelvic floor relaxation, self-massage with vaginal wands, and virtual PFPT visits. CONCLUSION: A stepwise approach to the treatment of HTPFD is recommended, with patients often necessitating multiple lines of treatment either sequentially or in conjunction. However, PFPT should be offered first line.


  • A Pilot Randomized Controlled Trial of Vaginal Cryotherapy for the Treatment of Pelvic Floor Myofascial Pain

    by Haidy Morsy, Melanie Meister, Theresa Spitznagle, Carter Scott, Tianyi Zhang, Chiara Ghetti, Christine Chu, Siobhan Sutcliffe, Jerry L. Lowder

    Introduction and hypothesis Pelvic floor myofascial pain (PFMP) is a common but underrecognized component of chronic pelvic pain and pelvic floor disorders symptoms with limited, well-studied treatment modalities. Our objective was to determine the effect of vaginal cryotherapy on PFMP with palpation. Methods Following a standardized PFMP screening examination, individuals with a pain score ≥4/10 in ≥1 of four muscle groups were invited to participate in a randomized controlled trial comparing patients undergoing vaginal cryotherapy with controls. Participants in both arms could choose to participate in a single in-office treatment; a 2-week, at-home daily treatment; or both. Results Between March 2019 and September 2021, a total of 163 participants were enrolled and randomized: 80 to cryotherapy, and 83 to the control group. Sixty-three (28 cryotherapy; 35 controls) completed in-office treatment and 56 (32 cryotherapy; 24 controls) completed at-home therapy. In the in-office comparison, mean pain scores decreased significantly in both arms: cryotherapy (5.13 vs 4.10; p=0.02) and controls (5.60 vs 4.72; pp=0.75). In the at-home comparison, mean pain scores decreased significantly in the cryotherapy arm (6.34 vs 4.75; pp=0.07), resulting in a nonsignificant difference between arms (p=0.14). Conclusions Pelvic floor myofascial pain with palpation improved following both a single cryotherapy session and 2 weeks of daily cryotherapy. Interestingly, pain scores also improved with room temperature therapy. Whether these findings reflect a therapeutic effect of both cold and room temperature intravaginal therapy or a placebo effect is unclear but should be explored in larger studies.


  • Open Access

    Myofascial Frequency Syndrome: A novel syndrome of bothersome lower urinary tract symptoms associated with myofascial pelvic floor dysfunction

    by A. Lenore Ackerman, Nicholas J. Jackson, Ashley T. Caron, Melissa R. Kaufman, Jonathan C. Routh, Jerry L. Lowder

    Background: Patients presenting with lower urinary tract symptoms (LUTS) are historically classified to several symptom clusters, primarily overactive bladder (OAB) and interstitial cystitis/bladder pain syndrome (IC/BPS). Accurate diagnosis, however, is challenging due to overlapping symptomatic features, and many patients do not readily fit into these categories. To enhance diagnostic accuracy, we previously described an algorithm differentiating OAB from IC/BPS. Herein, we sought to validate the utility of this algorithm for identifying and classifying a real-world population of individuals presenting with OAB and IC/BPS and characterize patient subgroups outside the traditional LUTS diagnostic paradigm. Methods: An Exploratory cohort of 551 consecutive female subjects with LUTS evaluated in 2017 were administered 5 validated genitourinary symptom questionnaires. Application of the LUTS diagnostic algorithm classified subjects into controls, IC/BPS, and OAB, with identification of a novel group of highly bothered subjects lacking pain or incontinence. Symptomatic features of this group were characterized by statistically significant differences from the OAB, IC/BPS and control groups on questionnaires, comprehensive review of discriminate pelvic exam, and thematic analysis of patient histories. In a Reassessment cohort of 215 subjects with known etiologies of their symptoms (OAB, IC/BPS, asymptomatic microscopic hematuria, or myofascial dysfunction confirmed with electromyography), significant associations with myofascial dysfunction were identified in a multivariable regression model. Pre-referral and specialist diagnoses for subjects with myofascial dysfunction were catalogued. Findings: Application of a diagnostic algorithm to an unselected group of 551subjects presenting for urologic care identified OAB and IC/BPS in 137 and 96 subjects, respectively. An additional 110 patients (20%) with bothersome urinary symptoms lacked either bladder pain or urgency characteristic of IC/BPS and OAB, respectively. In addition to urinary frequency, this population exhibited a distinctive symptom constellation suggestive of myofascial dysfunction characterized as “persistency ” : bothersome urinary frequency resulting from bladder discomfort/pelvic pressure conveying a sensation of bladder fullness and a desire to urinate. On examination, 97% of persistency patients demonstrated pelvic floor hypertonicity with either global tenderness or myofascial trigger points, and 92% displayed evidence of impaired muscular relaxation, hallmarks of myofascial dysfunction. We therefore classified this symptom complex “myofascial frequency syndrome”. To confirm this symptom pattern was attributable to the pelvic floor, we confirmed the presence of “persistency” in 68 patients established to have pelvic floor myofascial dysfunction through comprehensive evaluation corroborated by symptom improvement with pelvic floor myofascial release. These symptoms distinguish subjects with myofascial dysfunction from subjects with OAB, IC/BPS, and asymptomatic controls, confirming that myofascial frequency syndrome is a distinct LUTS symptom complex. Interpretation: This study describes a novel, distinct phenotype of LUTS we classified as myofascial frequency syndrome in approximately one-third of individuals with urinary frequency. Common symptomatic features encompass elements in other urinary syndromes, such as bladder discomfort, urinary frequency and urge, pelvic pressure, and a sensation of incomplete emptying, causing significant diagnostic confusion for providers. Inadequate recognition of myofascial frequency syndrome may partially explain suboptimal overall treatment outcomes for women with LUTS. Recognition of the distinct symptom features of MFS (persistency) should prompt referral to pelvic floor physical therapy. To improve our understanding and management of this as-yet understudied condition, future studies will need to develop consensus diagnostic criteria and objective tools to assess pelvic floor muscle fitness, ultimately leading to corresponding diagnostic codes. Funding: This work was supported by the AUGS/Duke UrogynCREST Program (R25HD094667 (NICHD)) and by NIDDK K08 DK118176 and Department of Defense PRMRP PR200027, and NIA R03 AG067993.